Skip to main content
. Author manuscript; available in PMC: 2014 Jul 10.
Published in final edited form as: Breast Cancer Res Treat. 2011 Jul 15;130(3):981–991. doi: 10.1007/s10549-011-1667-z

Table 4.

Odds ratios for developing lymphedema or arm symptoms according to presence of tumor positive lymph nodes at diagnosis by any history of radiation treatment (no/unknown vs. yes)

Variable Lymphedemaa,c Arm symptomsb,c
Negative nodes Positive nodes Negative nodes Positive nodes
Radiation axilla
 No/unknown 1.0 (referent)
n=62 Ld
n=435 NLf
1.0 (referent)
n=11 L
n=67 NL
1.0 (referent)
n=286 ASe
n=435 NL
1.0 (referent)
n=55 AS
n=67 NL
 Yes 0.55 (0.15, 1.96)
n=3 L
n=36 NL
7.1 (1.77, 28.58)
n=9 L
n=11 NL
1.53 (0.89, 2.60)
n=31 AS
n=36 NL
5.16 (1.85, 14.39)
n=21AS
n=11 NL
Pinteraction = 0.01 Pinteraction = 0.21
Radiation breast
 No/unknown 1.0 (referent)
n=46 L
n=320 NL
1.0 (referent)
n=8 L
n=59 NL
1.0 (referent)
n=222 AS
n=320 NL
1.0 (referent)
n=45 AS
n=59 NL
 Yes 0.85 (0.45, 1.56)
n=19 L
n=151 NL
4.90 (1.43, 16.81)
n=12 L
n=19 NL
1.01 (0.73, 1.41)
n=95 AS
n=151 NL
4.29 (1.81, 10.16)
n=31 AS
n=19 NL
Pinteraction = 0.04 Pinteraction = 0.02
a

Comparing participants with lymphedema to participants without lymphedema or symptoms.

b

Comparing participants with arm symptoms without diagnosed lymphedema to participants without lymphedema or symptoms.

c

Adjusted for baseline age, BMI (categories), history of smoking (categories and pack-years, continuous), occupational history (categories), general health at baseline (categories), tumor stage (categories), tumor size (categories), and history of chemotherapy (yes/no).

d

L = BrCa survivors with lymphedema.

e

AS = BrCa survivors with arm symptoms without a history of lymphedema.

f

NL = BrCa survivors without lymphedema or arm symptoms.